Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 1,842,118	$ 7,705,773
Prepaid expenses and other current assets	16,284
Total Current Assets	1,858,402	7,705,773
Equipment and furnishings, less accumulated depreciation of $421,377 and $416,798	31,417	20,111
Patents, net of amortization of $6,621,717 and $6,118,377, respectively	5,093,728	5,597,068
Other assets	27,000	27,000
Total Assets	7,010,547	13,349,952
Current Liabilities
Accounts payable - trade	280,615	101,102
Accrued compensation and payroll taxes	1,433,481
Accrued consulting expense	102,000	71,000
Other accrued expenses	139,000	90,622
Total Current Liabilities	1,955,096	262,724
Long-Term Liability
Warrant liability	1,631,590	3,067,488
Total Liabilities	3,586,686	3,330,212
Stockholders' Equity
Preferred stock; par value $.001 per share; 25,000,000 shares authorized; 2,941,665 and 3,531,665 shares issued and outstanding, respectively, liquidation preference $0.75 per share (in aggregate $2,250,133 and $2,702,134, respectively)	2,941	3,531
Common stock; par value $.001 per share; 200,000,000 authorized; 113,701,071 and 110,596,798 shares issued and outstanding, respectively	113,701	110,597
Paid-in capital	119,739,223	115,690,334
Deficit accumulated during the development stage	(116,432,004)	(105,784,722)
Total Stockholders' Equity	3,423,861	10,019,740
Total Liabilities and Stockholders' Equity	$ 7,010,547	$ 13,349,952